Q1 2024 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2024-05-15 · accession 0000950142-24-001354
$4.31B
Reported value
22
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G29018101 | DLO | DLOCAL | $939.4M | 21.8% | 63,906,695 | Common | SOLE |
| G98239109 | XP | XP, INC | $760.0M | 17.7% | 29,617,733 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $460.2M | 10.7% | 18,729,806 | Common | SOLE |
| 433537107 | — | HIRERIGHT | $458.2M | 10.6% | 32,109,898 | Common | SOLE |
| 85225A107 | 8DT | SQUARESPACE | $386.7M | 8.98% | 10,611,073 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $302.5M | 7.03% | 60,993,323 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $174.0M | 4.04% | 7,531,252 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $170.2M | 3.95% | 13,110,492 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $132.2M | 3.07% | 5,233,989 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $109.4M | 2.54% | 9,681,818 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE | $97.9M | 2.27% | 1,506,684 | Common | SOLE |
| 44842L103 | HCM | HUTCHMED | $67.2M | 1.56% | 4,000,000 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS | $62.2M | 1.44% | 19,132,440 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $45.6M | 1.06% | 1,500,000 | Common | SOLE |
| 60741F104 | MBLY | MOBILEYE | $38.4M | 0.89% | 1,194,839 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $28.8M | 0.67% | 5,324,998 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO | $27.9M | 0.65% | 2,958,762 | Common | SOLE |
| 00445A100 | — | ACELYRIN | $19.5M | 0.45% | 2,889,668 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR | $19.2M | 0.44% | 6,321,519 | Common | SOLE |
| 21077C305 | 5ZZ0 | WISH | $3.5M | 0.08% | 609,616 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $1.6M | 0.04% | 936,020 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $739,200 | 0.02% | 264,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.